Market Insights

As per recent research by MarkNtel Advisors, The Global Autoimmune Disorder Drug Delivery Devices Market is projected to witness 16.89% growth during the forecast period, i.e., 2022-27.

Growth Driver: Rising Geriatric Population

The selection of T-cells with increased affinity to self-antigens, and latent viruses, which result in the aging of the immune system, are the major factors contributing to an increase in autoimmune disorders in the elderly age population globally. According to the World Health Organization (WHO), the number of people aged over 60 is expected to nearly double from 12% to 22% by 2050.

Furthermore, globally, the aging population & increased immune disorders such as Alzheimer's Disease, Rheumatoid Arthritis, diabetes, etc., combined with the decrease in gastric pH, which limits drug absorption, are leading to an increase in demand for autoimmune disorder drug delivery devices.

“In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/global-autoimmune-disorder-drug-delivery-devices-market.html

Market Segmentation and Consumer Behavior:

  • By Product Type
    • Prefilled Syringes
    • Auto-injectors
    • Infusion pumps
    • Nebulizers
    • Nasal sprays
    • Others (Eyedropper, Transdermal patches, etc.)
  • By Indication
    • Psoriasis
    • Rheumatoid Arthritis
    • Multiple Sclerosis
    • Inflammatory Bowel Diseases
    • Systemic Lupus Erythematosus
    • Diabetes Mellitus
    • Others (Guillain Barre Syndrome, Grave’s Disease, etc.)
  • By Manufacturing Type   
    • In-House Manufacturing
    • Outsourced Manufacturing
  • By End User
    • Hospitals
    • Diagnostic centres
    • Ambulatory surgery centres
    • Others (Clinics, Home care settings, etc.)

Read Full Report: https://www.marknteladvisors.com/research-library/global-autoimmune-disorder-drug-delivery-devices-market.html

Autoimmune Disorder Drug Delivery Devices Market Geographical Analysis:

By Region:

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

Key Players and Competitive Strategies in the Autoimmune Disorder Drug Delivery Devices Market

Several prominent players dominate the Autoimmune Disorder Drug Delivery Devices Market, including:

  • Amgen Inc.
  • AbbVie Inc.
  • Bayer AG
  • Biogen Inc.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • The Merck Group
  • Novartis International AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • UCB Pharma SA.

Report Delivery - MarkNtel Advisors offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

1.What factors are driving the Autoimmune Disorder Drug Delivery Devices Market growth?

2.How is the Autoimmune Disorder Drug Delivery Devices Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Autoimmune Disorder Drug Delivery Devices Market?

4.What is the current size of the Autoimmune Disorder Drug Delivery Devices Market, and how is it projected to change in the future?

6.What is the future outlook for the Autoimmune Disorder Drug Delivery Devices Market in terms of technological advancements and market expansion?

Request Customization - https://www.marknteladvisors.com/query/request-customization/global-autoimmune-disorder-drug-delivery-devices-market.html

Read More:

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India